Aida Pharmaceuticals Inc
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet,… Read more
Aida Pharmaceuticals Inc (AIDA) - Total Assets
Latest total assets as of September 2008: $73.99 Million USD
Based on the latest financial reports, Aida Pharmaceuticals Inc (AIDA) holds total assets worth $73.99 Million USD as of September 2008.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Aida Pharmaceuticals Inc - Total Assets Trend (2004–2007)
This chart illustrates how Aida Pharmaceuticals Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Aida Pharmaceuticals Inc - Asset Composition Analysis
Current Asset Composition (December 2007)
Aida Pharmaceuticals Inc's total assets of $73.99 Million consist of 57.8% current assets and 42.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 13.4% |
| Accounts Receivable | $10.83 Million | 17.3% |
| Inventory | $3.84 Million | 6.1% |
| Property, Plant & Equipment | $17.02 Million | 27.1% |
| Intangible Assets | $9.03 Million | 14.4% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2004–2007)
This chart illustrates how Aida Pharmaceuticals Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aida Pharmaceuticals Inc's current assets represent 57.8% of total assets in 2007, a decrease from 72.4% in 2004.
- Cash Position: Cash and equivalents constituted 13.4% of total assets in 2007, up from 11.1% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, an increase from 3.0% in 2004.
- Asset Diversification: The largest asset category is property, plant & equipment at 27.1% of total assets.
Aida Pharmaceuticals Inc Competitors by Total Assets
Key competitors of Aida Pharmaceuticals Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Aida Pharmaceuticals Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Aida Pharmaceuticals Inc generates 0.47x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Aida Pharmaceuticals Inc generates $ 4.37 in net profit.
Aida Pharmaceuticals Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.73 | 0.77 | 0.79 |
| Quick Ratio | 0.60 | 0.66 | 0.67 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-12.09 Million | $ -8.85 Million | $ -5.85 Million |
Aida Pharmaceuticals Inc - Advanced Valuation Insights
This section examines the relationship between Aida Pharmaceuticals Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.77 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 16.6% |
| Total Assets | $62.73 Million |
| Market Capitalization | $1.80 USD |
Valuation Analysis
Below Book Valuation: The market values Aida Pharmaceuticals Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Aida Pharmaceuticals Inc's assets grew by 16.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Aida Pharmaceuticals Inc (2004–2007)
The table below shows the annual total assets of Aida Pharmaceuticals Inc from 2004 to 2007.
| Year | Total Assets | Change |
|---|---|---|
| 2007-12-31 | $62.73 Million | +16.58% |
| 2006-12-31 | $53.81 Million | +26.14% |
| 2005-12-31 | $42.66 Million | +68.97% |
| 2004-12-31 | $25.25 Million | -- |